Healthcare -
Biotechnology - NASDAQ - US
$ 17.37
-0.934 %
$ 2.18 B
Market Cap
-11.27
P/E
APLS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities APLS - Apellis Pharmaceuticals, Inc.
149 M
LAST VALUE
-36.11%
2 YEAR CAGR
-17.42%
5 YEAR CAGR
23.00%
10 YEAR CAGR